Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin)

Investigational New Drugs

Volumn 27, Issue 3, 2009, Pages 241-245

  Ouchi, Masaaki ^a   Kawamura, Hitoshi ^a   Urata, Yasuo ^a   Fujiwara, Toshiyoshi ^b  

^a National Institute of Infectious Diseases   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adenovirus; Cidofovir; Clinical trial; HTERT; Oncolytic virus

Indexed keywords

CIDOFOVIR; ONCOLYTIC ADENOVIRUS; TELOMERASE REVERSE TRANSCRIPTASE;

ADENOVIRAL E1A GENE; ADENOVIRUS; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA VIRUS; DRUG SAFETY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OBP-301 VIRUS; PRIORITY JOURNAL; PROMOTER REGION; VIREMIA; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN;

ADENOVIRIDAE; ANTIVIRAL AGENTS; CELL LINE, TUMOR; CYTOPATHOGENIC EFFECT, VIRAL; CYTOSINE; HUMANS; LUNG NEOPLASMS; ONCOLYTIC VIRUSES; PHOSPHONIC ACIDS; TELOMERASE; VIRUS REPLICATION;

EID: 64649089999     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-008-9169-5     Document Type: Article

References (20)

1. D Kirn RL Martuza J Zwiebel 2001 Replication-selective virotherapy for cancer: biological principles, risk management and future directions Nat Med 7 781 787
2. D Kirn 2000 Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer Oncogene 19 6660 6669
3. RL Chu DE Post FR Khuri EG Van Meir 2004 Use of replicating oncolytic adenoviruses in combination therapy for cancer Clin Cancer Res 10 5299 5312
4. JJ Davis B Fang 2005 Oncolytic virotherapy for cancer treatment: challenges and solutions J Gene Med 7 1380 1389
5. TM Nakamura GB Morfin KB Chapman SL Weinrich WH Andrews J Lingner 1997 Telomerase catalytic subunit homologs from fission yeast and human Science 277 955 959
6. NW Kim MA Piatyszek KR Prowse CB Harley MD West PL Ho 1994 Specific association of human telomerase activity with immortal cells and cancer Science 266 2011 2015
7. T Kawashima S Kagawa N Kobayashi Y Shirakiya T Umeoka F Teraishi 2004 Telomerase-specific replication-selective virotherapy for human cancer Clin Cancer Res 10 285 292
8. M Taki S Kagawa M Nishizaki H Mizuguchi T Hayakawa S Kyo 2005 Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 (Telomelysin-RGD) Oncogene 24 3130 3140
9. Y Hashimoto Y Watanabe Y Shirakiya F Uno S Kagawa H Kawamura 2008 Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus Cancer Sci 99 385 390
10. YJ Gordon E Romanowski T Araullo-Cruz L Seaberg S Erzurum R Tolman 1991 Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'¢-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro Antivir Res 16 11 16
11. E De Clercq 2003 Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections Clin Microbiol Rev 16 569 596
12. H Kishimoto T Kojima Y Watanabe S Kagawa T Fujiwara F Uno 2006 In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus Nat Med 12 1213 1219
13. T Reid E Galanis J Abbruzzese D Sze LM Wein J Andrews 2002 Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints Cancer Res 62 6070 6079
14. RJ Whitley B Roizman 2001 Herpes simplex virus infection Lancet 357 1513 1518
15. KK Biron 2006 Antiviral drugs for cytomegalovirus diseases Antivir Res 71 154 163
16. L Naesens L Lenaerts G Andrei R Snoeck D Van Beers A Holy 2005 Antiadenovirus activities of several classes of nucleoside and nucleotide analogues Antimicrob Agents Chemother 49 1010 1016
17. F Morfin S Dupuis-Girod S Mundweiler D Falcon D Carrington P Sedlacek 2005 In vitro susceptibility of adenovirus to antiviral drugs is species-dependent Antivir Ther 10 225 229
18. PR Kinchington T Araullo-Cruz JP Vergnes K Yates YJ Gordon 2002 Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir Antivir Res 56 73 84
19. K Toth JF Spencer D Dhar JE Sagartz RM Buller GR Painter 2008 Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model Proc Natl Acad Sci U S A 105 7293 7297.
20. YJ Gordon TP Araullo-Cruz YF Johnson EG Romanowski PR Kinchington 1996 Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir Invest Ophthalmol Vis Sci 37 2774 2778